COMMUNIQUÉS West-GlobeNewswire

Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference
29/05/2024
CAMBRIDGE, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in [...]
Lipella Pharmaceuticals Announces Abstract Publication at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
29/05/2024
Abstract highlighting new preclinical data from LP-50 in non-muscle invasive bladder cancer PITTSBURGH, May 29, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella,” “our,” “us” or the “ [...]
Spinogenix Announces FDA Clearance of IND Application for SPG302, a Novel Therapy for the Treatment of ALS
29/05/2024
SPG302 is being developed as a once-a-day pill with the potential to regenerate synapses to reverse declines in cognitive and motor function in people with ALS SAN DIEGO, May 29, 2024 (GLOBE NEWSWIRE) -- Spinogenix, Inc [...]
Collegium to Participate in Jefferies Global Healthcare Conference
29/05/2024
STOUGHTON, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious [...]
CRISPR Therapeutics to Participate in Upcoming Investor Conferences
29/05/2024
ZUG, Switzerland and BOSTON, May 29, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced [...]
Tevogen Bio Reports First Quarter 2024 Financial Results
29/05/2024
Confirms liability elimination of $94.9 million and discloses $11.3 million of net income Reports net cash used for operating activities was $2.1 million Reiterates commitment to both patients and shareholders WARREN, N [...]
Largest study on the LRRK2 variant leads to discoveries about health, ancestry, and history
29/05/2024
Findings from 23andMe research on Parkinson’s disease published in Brain The LRRK2 variant is strongly associated with symptoms of Parkinson’s disease (PD) that are different from non-variant carriers with the disease [...]
Clover Health Announces Counterpart Health, a New SaaS and Tech Enabled Services Solution to Bring the Power of CA Technology to all Medicare Advantage Payors and Providers
29/05/2024
FRANKLIN, Tenn., May 29, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”) , a physician enablement technology company committed to bringing access to [...]
Merus to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference
29/05/2024
UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- Merus N.V . (Nasdaq: MRUS), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics ® and [...]
Nusano Expands Executive Management to Support Q1 2025 Radioisotope Commercialization
29/05/2024
VALENCIA, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- Nusano, Inc., a physics company transforming the production of medical radioisotopes, today announced the addition of three executives to enhance and expand key [...]
GTG Launches Revolutionary geneType Test covering 100% Risk of Breast and Ovarian Cancer
29/05/2024
MELBOURNE, Australia, May 29, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and serious disease, is pleased [...]
Cabaletta Bio to Participate in the Jefferies Global Healthcare Conference
29/05/2024
PHILADELPHIA, May 29, 2024 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed [...]
Castellum, Inc. Announces Leadership Changes
29/05/2024
VIENNA, Va., May 29, 2024 (GLOBE NEWSWIRE) -- Castellum, Inc. (the “Company” or “Castellum”) (NYSE-American: CTM), a cybersecurity, electronic warfare, and software services company focused on the federal government, [...]
Casey House creates fictitious drug, Stigmavir, to smash HIV stigma within the health care system
29/05/2024
Specialty hospital uses Gloria Gaynor's I will Survive to create a PSA that calls on health care practitioners to deliver equitable care for those living with HIV TORONTO, May 29, 2024 (GLOBE NEWSWIRE) -- Casey House – [...]
Affimed Receives Fast Track Designation for Combination Therapy of AFM24 with Atezolizumab for EGFR Wild-Type Non-Small Cell Lung Cancer
29/05/2024
Efficacy and safety of AFM24 in combination with atezolizumab, a checkpoint inhibitor, is being evaluated in non-small cell lung cancer patients with EGFR wild-type and EGFR mutant advanced/metastatic cancers in the [...]
Listen in on ALK’s Capital Markets Day on 4 June 2024
29/05/2024
ALK ( ALKB:DC / OMX: ALK B / AKBLF ) will host a Capital Markets Day on 4 June at 13.00-17.00. We cordially invite investors, analysts, and other interested stakeholders to listen in on our Capital Markets Day 2024, [...]
Curium Extends Irradiation Partnership With NRG I PALLAS in Netherlands for Continuous Supply of Lutetium-177 to Treat 1,000s of Cancer Patients Each Year
29/05/2024
PARIS, May 29, 2024 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, today announced that it has signed a long-term agreement to extend its current partnership with NRG I PALLAS for new irradiation [...]
Cytosurge's CellEDIT Workflow, based on its Proprietary FluidFM® Technology, Receives Validation in Peer-Reviewed Publication
29/05/2024
CellEDIT Service represents a novel workflow leveraging FluidFM-mediated intranuclear nanoinjection of CRISPR/Cas9 components into single cells. Control of the amount and stoichiometry of RNP complexes could boost [...]
Anaveon announces IND approval of ANV600-001 (EXPAND) Phase I/II clinical study
29/05/2024
ANV600 combines a non-blocking α PD-1 antibody and an IL-2Rβ/γ selective agonist targeting IL-2 to tumor-specific T cells resulting in proliferation and increase of tumor-killing potential BASEL, Switzerland, May 29, [...]

Pages